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Abstract
We present the case of a young adult with stroke and very mild
coronavirus disease 2019 (COVID-19). Results of hematologic
work-up suggest SARS-CoV-2-induced endotheliitis. No
concurrent etiology for stroke was detected. This case illustrates
the possibility of stroke in healthy SARS-CoV-2-infected patients
without hyperinflammatory state or excessive systemic
coagulation activation.
© 2020 The Authors. Published by Elsevier Ltd.
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We describe a previously healthy 24-year-old man who pre-
sented with a 1-day history of left-sided paresthesia, arm
weakness and hemiataxia, homonymous hemianopsia and gait
instability (National Institutes of Health Stroke Scale (NIHSS)
4). Twenty-four hours earlier he had noted a fever (tempera-
ture 38.5°C), nausea and right-sided headache but denied any
respiratory symptoms. He was not receiving any medication
and denied any illicit drug use.
At presentation, the patient was in good general condition;
vital signs were normal. Chest radiograph was unremarkable;
C-reactive protein was 13 mg/L (reference, <8 mg/L). Cerebral
imaging (computed tomography and magnetic resonance im-
aging) showed ischaemic stroke in the territory of the right
posterior cerebral artery with persisting thrombus (P1/2
segment) (Fig. 1). Cerebrospinal fluid (CSF) showed slightly
elevated proteins of 0.59 g/L (reference, 0.15–0.45 g/L); cell
count and glucose and lactate levels were normal. PCR of
nasopharyngeal swab and stool samples was performed and was
positive for severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2); PCR testing of blood and CSF samples remained
negative.
Investigations for other infectious agents (influenza A/B,
syphilis, HIV, hepatitis B/C, varicella, herpes simplex, Borrelia
burgdorferi) were negative, except for Mycoplasma
pneumoniae–specific IgM and IgG antibodies, which were pos-
itive at low levels. An acute M. pneumoniae infection was
excluded by negative nasopharyngeal and CSF PCR results,
negative antibody-secreting cell (ASC) enzyme– linked immu-
nospot (ELISpot) assay results and by follow-up serology, which
did not show significant changes. Blood culture testing and cold
agglutinin and autoantibody screening were negative.
Transesophageal echocardiography did not reveal any car-
diac thrombus, endocarditis or patent foramen ovale. Long-
term electrocardiogram monitoring was unremarkable. Coag-
ulation assessment 3 days after admission revealed markedly
elevated factor VIII at 321% (reference, 50–150%) and von
Willebrand factor activity at 198% (reference, 65–145%);
however, no signs of systemic blood coagulation activation
were evident (nonelevated D-dimers and prothrombin frag-
ments), suggesting vascular endothelial dysfunction. Classical
hereditary thrombophilia, lupus anticoagulant and anti-
phospholipid antibodies were excluded later in the course.
The patient was treated with acetylsalicylic acid, enoxaparin
and hydroxychloroquine and was discharged to a rehabilitation
hospital 14 days after hospital admission. Antibody testing
against SARS-CoV-2 at 6 weeks after initial presentation
showed positive IgG and negative IgM.
We present the case of a previously healthy young adult with
stroke in the context of very mild coronavirus disease 2019
(COVID-19). Extensive assessment did not reveal any other
infectious or noninfectious cause. Ischaemic stroke has been
reported in association with COVID-19, particularly among the
elderly and those with a severe disease course [1,2]. Coagul-
opathy and vascular endothelial dysfunction have been dis-
cussed as complications of COVID-19 [3]. Although not
proven, results of haematologic assessment in our patient
suggested SARS-CoV-2– induced endotheliitis as the underlying
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pathomechanism. Indeed, SARS-CoV-2 has been shown to
attack angiotensin-converting enzyme 2 receptors in endothe-
lial cells causing endotheliitis, thereby disrupting the integrity of
the blood vessel wall [4]. In a report of three COVID-19 pa-
tients with mesenteric ischaemia, histopathology identified viral
elements and accumulation of inflammatory cells associated
with endothelial cells [5].
This case illustrates the possibility of stroke in healthy SARS-
CoV-2– infected patients without evidence of a hyper-
inflammatory state or excessive systemic coagulation activation.
We recommend measuring factor VIII and von Willebrand
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FIG. 1. (Left) Diffusion-weighted magnetic resonance imaging scan of right hemispheric thalamus, hippocampus and occipital ischaemia. (Right) Time-
of-flight magnetic resonance angiography of right posterior cerebral artery with partially autolyzed rest thrombus.
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